J. Fitzgerald
Molecular Biology · with Nielsen · 2006
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 10 citations into it
Whom J. Fitzgerald trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Fitzgerald's perspective
Ordered by how strongly the researchers J. Fitzgerald trusts endorse each paper. Same corpus, a different order for every researcher.
- Cell-signalling dynamics in time and space (Nature reviews. Molecular cell biology)
- The problem of synergism and antagonism of combined drugs.
- The tor pathway: a target for cancer therapy (Nature Reviews. Cancer)
- The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
- mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
- Systematic discovery of multicomponent therapeutics (Proceedings of the National Academy of Sciences of the United States of America)
- Multicomponent therapeutics for networked systems (Nature reviews. Drug discovery)
- Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors (Nature Biotechnology)
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancer (Nature Reviews. Cancer)
Their papers
- Systems biology and combination therapy in the quest for clinical efficacy (2006) — 582 citations